{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:01:09Z","timestamp":1761541269835,"version":"3.33.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ijcard.2015.09.006","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T15:18:18Z","timestamp":1442071098000},"page":"214-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Paroxysmal atrial fibrillation and the hazards of under-treatment"],"prefix":"10.1016","volume":"202","author":[{"given":"Konstantinos N.","family":"Aronis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Thigpen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yorghos","family":"Tripodis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1146-7776","authenticated-orcid":false,"given":"Chrisly","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Forster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Henault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily Kate","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter B.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nita A.","family":"Limdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine M.","family":"Hylek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.09.006_bb0005","first-page":"e6","article-title":"Heart disease and stroke statistics\u20142013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0015","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1161\/STR.0b013e31829734f2","article-title":"Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association","volume":"44","author":"Ovbiagele","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0020","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0025","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.ehj.2004.06.030","article-title":"Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke Registry","volume":"25","author":"Steger","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0030","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0035","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.STR.0000230607.07928.17","article-title":"Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002)","volume":"37","author":"Lakshminarayan","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0040","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1747-4949.2011.00672.x","article-title":"Impact of anticoagulation before stroke on stroke severity and long-term survival","volume":"7","author":"Haeusler","year":"2012","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0045","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/STROKEAHA.111.630731","article-title":"Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants","volume":"43","author":"Fang","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0050","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/STROKEAHA.110.602235","article-title":"Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study","volume":"42","author":"Hannon","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0055","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0060","article-title":"AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on practice Guidelines and the Heart Rhythm Society","volume":"2014","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0065","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cjca.2012.01.021","article-title":"Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate\/rhythm control","volume":"28","author":"Skanes","year":"2012","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2296-13-5","article-title":"Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis","volume":"13","author":"Baczek","year":"2012","journal-title":"BMC Fam. Pract."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1600-0404.107.s179.7.x","article-title":"Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease","volume":"179","author":"Arnaiz","year":"2003","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0085","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"Waldo","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0090","first-page":"S451","article-title":"An economic model of stroke in atrial fibrillation: the cost of suboptimal oral anticoagulation","volume":"10","author":"Caro","year":"2004","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0095","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1161\/CIRCULATIONAHA.107.181486","volume":"115","author":"Adams","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0100","first-page":"541","article-title":"Experience from a multicentre stroke register: a preliminary report","volume":"54","author":"Hatano","year":"1976","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0105","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.5603\/KP.a2013.0179","article-title":"Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland","volume":"71","author":"Bednarski","year":"2013","journal-title":"Kardiol. Pol."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0110","doi-asserted-by":"crossref","first-page":"e67806","DOI":"10.1371\/journal.pone.0067806","article-title":"Frequency and risk factors for under- and over-treatment in stroke prevention for patients with non-valvular atrial fibrillation in general practice","volume":"8","author":"Arts","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0115","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry","volume":"8, e63479","author":"Kakkar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0120","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.thromres.2006.12.019","article-title":"Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: the appropriate use and barriers to oral anticoagulant therapy","volume":"120","author":"Partington","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0125","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1538-7836.2005.01344.x","article-title":"Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome","volume":"3","author":"Paciaroni","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0130","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.06.006","article-title":"Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation","volume":"22","author":"Deguchi","year":"2013","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2796.2005.01512.x","article-title":"Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation","volume":"258","author":"Indredavik","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jns.2013.08.013","article-title":"Ischemic stroke in patients with atrial fibrillation receiving oral anticoagulation","volume":"334","author":"Pujol Lereis","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1468-1331.2012.03804.x","article-title":"Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study) CHADS(2), CHA(2) DS(2)-VASc score, underuse of oral anticoagulation, and implications for preventive measures","volume":"20","author":"Palm","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0150","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000330348","article-title":"Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients","volume":"32","author":"Rizos","year":"2011","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0155","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.05.013","article-title":"Paroxysmal atrial fibrillation in cryptogenic stroke: a case\u2013control study","volume":"22","author":"Rabinstein","year":"2013","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0160","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.jacc.2007.07.076","article-title":"Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W substudy","volume":"50","author":"Hohnloser","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0165","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2015.09.006_bb0170","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/1076029613491459","article-title":"Predictors of anticoagulant treatment in patients with nonvalvular atrial fibrillation: results from atrial fibrillation in Turkey: epidemiologic registry","volume":"21","author":"Kaya","year":"2015","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0175","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1540-8167.2005.00288.x","article-title":"Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation","volume":"17","author":"Klemm","year":"2006","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamainternmed.2013.1561","article-title":"Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study","volume":"173","author":"Verma","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0195","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0200","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1093\/eurheartj\/ehl015","article-title":"Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro heart survey on atrial fibrillation","volume":"27","author":"Nieuwlaat","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0205","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study","volume":"125","author":"Friberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0210","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2015.09.006_bb0215","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archinternmed.2012.4261","article-title":"Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding","volume":"172","author":"Witt","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0220","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/eurheartj\/ehr454","article-title":"Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation","volume":"33","author":"Raunso","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0225","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.09.006_bb0230","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315304472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315304472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T17:52:36Z","timestamp":1738000356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315304472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":46,"alternative-id":["S0167527315304472"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.09.006","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paroxysmal atrial fibrillation and the hazards of under-treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}